2410 — TYK Medicines Balance Sheet
0.000.00%
Last trade - 00:00- HK$4.23bn
- HK$3.99bn
Annual balance sheet for TYK Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 243 | 193 | 460 | 367 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 275 | 234 | 569 | 441 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 190 | 250 | 210 | 232 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 558 | 573 | 916 | 780 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 962 | 1,301 | 289 | 308 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1,064 | 1,458 | 447 | 493 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | -506 | -884 | 469 | 287 |
| Total Liabilities & Shareholders' Equity | 558 | 573 | 916 | 780 |
| Total Common Shares Outstanding |